Although this transgenic model may be representative of tau aggregation in inherited 4R tauopathies, this model is not representative of tau aggregation in Alzheimer's disease, in which there are no mutations in tau associated with the disease and in which both 3R and 4R tau aggregate. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.